LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.
Pharmaceutics
; 15(5)2023 May 18.
Article
in En
| MEDLINE
| ID: mdl-37242766
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Pharmaceutics
Year:
2023
Document type:
Article
Affiliation country:
Italia
Country of publication:
Suiza